Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabies Vaccine ID Regimens Study
NCT02177032Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2014
- Primary completion
- Oct 2014
- Modality
- Whole Inactivated Vaccines
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of rabies vaccine purified chick embryo cell in rabies (4 arms), sponsored by Novartis. Primary endpoint: Percentages of Subjects With RVNA Titer >= 0.5 IU/mL at Day 50. Started Jun 2014; status: completed.
02
Drugs
rabies vaccine purified chick embryo cell
03
Conditions
rabies
Beyond the preview
Go deeper on NCT02177032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177032.